LPAR2 expression is upregulated in gastric and colon cancers [31, 32], and also in dextrane sulfate sodium (DSS)-induced murine colitis [22, 33], and inhibition of LPAR2 attenuates both colitis and tumor formation [22, 34]. Here, LPAR2 is linked to colitis.